"Palivizumab" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A humanized monoclonal antibody and ANTIVIRAL AGENT that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.
| Descriptor ID |
D000069455
|
| MeSH Number(s) |
D12.776.124.486.485.114.224.060.860 D12.776.124.790.651.114.224.060.860 D12.776.377.715.548.114.224.200.860
|
| Concept/Terms |
MEDI 493- MEDI 493
- Monoclonal Antibody MEDI-493
- Monoclonal Antibody MEDI 493
- Monoclonal Antibody MEDI493
- MEDI-493
- MEDI493
|
Below are MeSH descriptors whose meaning is more general than "Palivizumab".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Blood Proteins [D12.776.124]
- Immunoproteins [D12.776.124.486]
- Immunoglobulins [D12.776.124.486.485]
- Antibodies [D12.776.124.486.485.114]
- Antibodies, Monoclonal [D12.776.124.486.485.114.224]
- Antibodies, Monoclonal, Humanized [D12.776.124.486.485.114.224.060]
- Palivizumab [D12.776.124.486.485.114.224.060.860]
- Serum Globulins [D12.776.124.790]
- Immunoglobulins [D12.776.124.790.651]
- Antibodies [D12.776.124.790.651.114]
- Antibodies, Monoclonal [D12.776.124.790.651.114.224]
- Antibodies, Monoclonal, Humanized [D12.776.124.790.651.114.224.060]
- Palivizumab [D12.776.124.790.651.114.224.060.860]
- Globulins [D12.776.377]
- Serum Globulins [D12.776.377.715]
- Immunoglobulins [D12.776.377.715.548]
- Antibodies [D12.776.377.715.548.114]
- Antibodies, Monoclonal [D12.776.377.715.548.114.224]
- Antibodies, Monoclonal, Humanized [D12.776.377.715.548.114.224.200]
- Palivizumab [D12.776.377.715.548.114.224.200.860]
Below are MeSH descriptors whose meaning is more specific than "Palivizumab".
This graph shows the total number of publications written about "Palivizumab" by people in this website by year, and whether "Palivizumab" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Palivizumab" by people in Profiles.
-
Respiratory syncytial virus morbidity and outpatient palivizumab dosing in South Carolina, 2004-2009. South Med J. 2012 Aug; 105(8):399-404.